Stay updated on SB12 Pharmacokinetics Safety in Healthy Subjects Clinical Trial
Sign up to get notified when there's something new on the SB12 Pharmacokinetics Safety in Healthy Subjects Clinical Trial page.

Latest updates to the SB12 Pharmacokinetics Safety in Healthy Subjects Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe study record for the SB12 eculizumab trial in healthy subjects is displayed, with its status, design, eligibility criteria, treatment arms, and measured outcomes.SummaryDifference46%

- Check17 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check24 days agoChange DetectedA site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check31 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check38 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record content and navigation with an access-denied notice. This prevents viewing the trial's details, contacts, and locations on this page.SummaryDifference18%

Stay in the know with updates to SB12 Pharmacokinetics Safety in Healthy Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SB12 Pharmacokinetics Safety in Healthy Subjects Clinical Trial page.